Eiko Lifesciences Ratios

Eiko Lifesciences Ltd Ratios

The Eiko Lifesciences Ltd Ratios page provides a complete fundamental analysis of Eiko Lifesciences Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Eiko Lifesciences Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Eiko Lifesciences Ltd (NSE: , BSE: 540204) is currently trading at ₹53.04, with a market capitalization of ₹0. As a major player in the Process industries sector and Chemicals: specialty industry, Eiko Lifesciences Ltd remains a key stock for fundamental analysis using Eiko Lifesciences Ltd Ratios.

Eiko Lifesciences Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Eiko Lifesciences Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Eiko Lifesciences Ltd Ratios.

Historically, the Eiko Lifesciences Ltd P/E ratio has shown strong fluctuations:

The decline in Eiko Lifesciences Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Eiko Lifesciences Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

Eiko Lifesciences Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Eiko Lifesciences Ltd P/S ratio currently stands at 0, an important part of Eiko Lifesciences Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining Eiko Lifesciences Ltd P/S ratio indicates cautious market sentiment.

Eiko Lifesciences Ltd Price to Cash Flow Ratio (P/CF)

The Eiko Lifesciences Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Eiko Lifesciences Ltd Price to Cash Flow Ratio:

The declining Eiko Lifesciences Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Eiko Lifesciences Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Eiko Lifesciences Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

Eiko Lifesciences Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Eiko Lifesciences Ltd EV/EBITDA ratio is currently 0, a key metric in Eiko Lifesciences Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable Eiko Lifesciences Ltd EV/EBITDA indicates balanced valuation.

Eiko Lifesciences Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Eiko Lifesciences Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

Eiko Lifesciences Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Eiko Lifesciences Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

Eiko Lifesciences Ltd Ratios Analysis Summary

The Eiko Lifesciences Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Eiko Lifesciences Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Eiko Lifesciences Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.